Check out important updates from the FDA for the week of June 3.

In a session presented at the 2024 Heart in Diabetes Conference, researchers discussed the abilities of continuous glucose monitoring (CGM) to capture lifestyle data and improve mortality rates.

Researchers addressed patients’ preferences for the delivery method of educational cancer resources as well as the demographics that were influenced to read materials or not.

Vaccinated men and women are at a reduced risk for HPV-related cancers, according to research presented at ASCO 2024.

In an abstract presented at ENDO 2024, researchers addressed practitioners’ current knowledge of CGM and their experience prescribing in low-income communities.

Dive in and learn more about the answers to yesterday’s quiz.

HbA1c levels decreased significantly after an average of 154 days in patients who used a continuous glucose monitor.

Four poster presented at ENDO 2024 examined the current landscape of diabetes.

Overdose deaths have decreased for the first time since 2018, but naloxone remains an important tool in fighting the opioid epidemic.

Test your knowledge different headache types.

The Psychopharmacologic Drugs Advisory Committee voted 10-1 that the benefits of MDMA do not outweigh its potential risks.

Check out this list of resources to share with patients who are managing a migraine or other headache diagnosis.

Posters presented at ENDO 2024 investigated excessive weight gain in breast cancer survivors and how high insulin levels impact outcomes for Black women with an aggressive form of the disease.

Study results were promising, but larger studies are needed.

In an abstract presented at the Endocrine Society’s ENDO 2024 annual meeting in Boston, Massachusetts, researchers addressed the association between social vulnerability and glycemic control in patients with diabetes.

Research presented at ENDO 2024 found that glucagon-like peptide-1 receptor agonists had a lower acute pancreatitis recurrence risk than SGLT2i, DPP4i, and no medication.

In an abstract presented at the Endocrine Society’s ENDO 2024 annual meeting in Boston, Massachusetts, researchers explored access to GLP-1s for teenagers with and without type 2 diabetes.

While elevated BMI at baseline was not associated with increased cardiovascular risk, cumulative excess BMI was associated with an increased risk in people under 50.

Higher serum testosterone concentration was not associated with a reduced risk of developing type 2 diabetes in men older than 65.

All Boehringer Ingelheim inhalers are included in the program and will be available for $35 per month for eligible patients.

Research presented at ENDO 2024 found that environmental stress increased the likelihood of earlier alcohol, nicotine and cannabis use in females and traumatic events increased the likelihood in males.

Check out this recap of articles published on our sister sites during the past week.

In case you missed it, this week we had news about AI's role in promoting skin cancer awareness, the legalization of edible cannabis, expanding the role of the pharmacist, and more.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Authors analyzed Section 804 of the Food, Drug, and Cosmetic Act (FDCA) allowing state-sponsored programs to bring Canadian drugs onto US soil.